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Abstract: It was evaluated the  in vitro efficacy of ethanolic extract of leaves and bark of Ximenia americana L and Schinopsis brasiliensis 
Engl. alone and in association with erythromycin as modulators of microbial resistance against six clinical isolates of Staphylococcus aureus 
resistant to erythromycin (SA1-SA6) and S. aureus ATCC 25923 by the microdilution method. The extracts were also subjected to bioassay 
with Artemia salina. The ethanolic extract of barks of X. americana showed a synergistic effect with erythromycin against SA01, SA03 and 
SA04. The leaf extract of S. brasiliensis exerted synergistic effect against SA03 and the bark extract showed against SA01 and S03. The 
results suggest that extracts from S.brasiliensis and X. americana have potential as modulator agents of bacterial resistance, which could be 
used as adjuvants in the treatment of infections by S. aureus resistant to erythromycin, with previous studies of toxicity. 
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Resumen: Se evaluó la eficacia in vitro de los extractos etanólicos de hojas y corteza de Ximenia americana L y Schinopsis brasiliensis 
Engl solos y en asociación con eritromicina como moduladores de la resistencia microbiana frente a seis aislados clínicos de Staphylococcus 
aureus resistentes a Eritromicina (SA1-SA6) y S. aureus ATCC 25923, por el método de microdilución. Además se determinó la actividad 
tóxica de los  extractos contra Artemia salina. Solo el extracto etanólico de la corteza de X. americana mostró un efecto sinérgico con la 
eritromicina  frente a  SA01, SA03 y SA04. El extracto de las hojas de S. brasiliensis ejerció efecto sinérgico contra SA03 y el extracto de 
corteza, contra SA01 y S03. Los resultados sugieren que S. brasiliensis y X. americana tienen potencial como agentes moduladores de la 
resistencia bacteriana, que podrían ser utilizados como adyuvantes en el tratamiento de infecciones por S. aureus resistentes a eritromicina, 
con estudios previos de toxicidad. 
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Recibido | Received: May 30, 2013 
Aceptado | Accepted: February 16, 2014 
Aceptado en versión corregida | Accepted in revised form: December 15, 2014 
Publicado en línea | Published online: March 30. 2015 
Este artículo puede ser citado como / This article must be cited as: KMA Silva, TP Chaves, RL Santos, DO Brandao, FHA Fernandes, FJL Ramos-Junior, VL Santos, DC 
Felismino, ACD Medeiros. 2015. Modulation of the erythromycin resistance in Staphylococcus aureus by ethanolic extracts of Ximenia americana L and Schinopsis brasiliensis 
Engl. Bol Latinoam Caribe Plant Med Aromat 14 (2): 92 – 98.  
 
da Silva et al. Modulation of the erythromycin resistance of medicinal plants 
 
 
Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas/93 
 
 
 
INTRODUCTION 
With the emergence of antimicrobial resistance of 
Staphylococcus aureus to conventional antibiotics 
(Silva et al., 2007), the treatment options for 
infections have become limited (Olajuyigbe & 
Afolayan, 2012) encouraging scientific research 
focused on the antibacterial properties of plant 
products. Such products have led to many drugs 
currently used in clinical practice (Coutinho et al., 
2009a; Coutinho et al., 2009b). 
The interest in plant extracts as active 
antibacterial is due to their complex combinations of 
secondary metabolites, complicating adaptability 
(Coutinho et al., 2009b). Currently, these extracts 
have been studied as active resistance modifiers, in 
which their efficacy is tested by combining such 
extracts with synthetic drugs, in order to obtain a 
synergistic effect or decreased side effects. This 
modification consists in the improvement of 
antimicrobial activity or reversal of microbial 
resistance (Gibbons, 2004; Coutinho et al., 2009a; 
Coutinho et al., 2009b; Celenza et al., 2012; Ncube et 
al., 2012).  
Brazil has a great potential for biodiversity 
and richness of traditional knowledge accumulated by 
the local people who have direct access to nature and 
the biodiversity of products. In this sense, the 
Caatinga (main semiarid’s biome) represents the 
fourth largest area covered by a single vegetation 
form in Brazil, accounting for about 60% of the 
northeast territory (Silva et al., 2012; Fernandes et 
al., 2013). 
Ximenia americana L., family Olacaceae, is 
found in the tropical regions of America and Africa 
tropical. It had its antibacterial efficacy on the main 
bacteria involved in nosocomial infections elucidated 
in several pharmacological studies (Ogunleye & 
Ibitoye, 2003; Omer & Elnima, 2003; James et al., 
2007; Kubmarawa et al., 2007; Maiakai et al., 2009; 
Silva et al., 2012). The chemical composition of X. 
americana has been scarcely investigated. The 
sambunigrin compound was isolated in the EtOAc-
soluble fraction of alcoholic extract from leaves. 
Gallic acid, gallotannins, and flavonoids were 
identified for the first time in the genus Ximenia 
(Fernandes et al., 2013). In recent years, fatty acids, 
volatile oil constituents, sesquiterpenes, triterpenes 
and phytosterols are reported from the seeds, leaves 
and stems (Le et al., 2012).  
Schinopsis brasiliensis Engler, 
Anacardiaceae family, distributed in the Brazilian 
semiarid region and popularly known as Braúna, 
Baraúna, is a species typical of Brazil whose leaves, 
bark, stems and fruits have broad popular use as 
antiseptic and anti-inflammatory (Chaves et al., 2011; 
Silva et al., 2012). Preliminary phytochemical studies 
showed that this plant has high content of phenolic 
compounds such as tannins and flavonoids (Saraiva 
et al., 2011). From this new plant was isolated the 
new alkyl phenol, methyl 6-eicosanyl-2-hydroxy-4-
methoxybenzoate, besides an unusual steroid 5α, 8α- 
epidioxyergosta-6,22-dien-3-β-ol (Cardoso et al., 
2005). 
The aim of this study was to evaluate the 
extracts of medicinal plants studied, such as 
modifying agents of Staphylococcus aureus resistant 
to erythromycin. 
 
MATERIALS AND METHODS  
Plant Material 
Leafs and bark of Ximenia americana L. (Olacaceae) 
and Schinopsis brasiliensis Engl. (Anacardiaceae) 
were collected in the semiarid region of Paraíba state, 
with the exsiccates prepared and identified in the 
herbarium Professor Jayme Coelho de Morais, 
Federal University of Paraíba, under the numbers 
EAN-100493 and EAN-14049, respectively. The 
plant materials were dried in circulating air oven at 
40 ± 1 °C and crushed into slicer with a particle size 
of 10 mesh. The powders of plants (100 g) were 
extracted with 1000 mL of 96% ethanol by 
maceration for five days and subsequently it was 
conducted the concentration on a rotary evaporator at 
40 °C. 
 
Minimal Inhibitory Concentration (MIC) 
Determination and Modulation activity  
The plant extracts were tested against the strains of 
Staphylococcus aureus clinical isolates (SA01, SA02, 
SA03, SA04, SA05, SA06) resistant to erythromycin 
(confirmed by antibiotic susceptibility test in 
triplicate) and, non-resistant strain of S. aureus 
(ATCC 25923). The microorganisms were grown on 
Mueller Hinton agar at 37 °C for 24 hours and kept in 
test tubes containing BHI agar. The Minimal 
Inhibitory Concentration (MIC) Determination was 
performed by the broth microdilution method. It was 
performed in 96 well microplates according to the 
Clinical and Laboratory Standards Institute 
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procedures (CLSI, 2009). The inoculums were 
standardized in tubes containing 5mL sterile 0.9% 
saline solution. The suspension was adjusted 
spectrophotometrically at 625 nm which is equivalent 
to 10
6
 CFU/mL. One hundred microlitres of each 
extract and antibiotic alone and in combination with 
the extracts were serially diluted threefold with sterile 
Mueller Hinton broth in a 96-well microlitre plate for 
each microorganisms strains studied. Ten microlitres 
of each microorganism culture were added to each 
well. Ethanol/water was included as negative 
controls. The plate incubated at 37 ºC ± 1 ºC for 24 h. 
Bacterial growth was indicated by adding 20 μL of 
aqueous solution of resazurin (Sigma-Aldrich) to 
0.01% with further incubation at 37 ºC ± 1 ºC  for 2 
h. Viable bacteria reduced the blue dye to a pink 
color. The MIC was defined as the lowest 
concentration that inhibited bacterial growth. 
In the resistance-modulating activity assay 
the MIC of the antibiotic was determined in the 
presence of sub-inhibitory concentration (MIC/8) of 
the extracts. The calculation of the fractional 
inhibitory concentration (FIC) was performed to 
obtain a coefficient that indicated whether the 
association with the antibiotic extract will produce 
synergistic effect (FIC < 0.5), indifferent (CIF > 0.5- 
< 4.0) or antagonistic (CIF > 4.0) (Mackay et al., 
2000). All the experiments were performed in 
triplicate. 
 
 
Bioassay with Artemia salina.  
This bioassay was performed with extracts that 
showed antibiofilm activity to evaluate the EtOH 
extract toxicity; it used the brine shrimp (Artemia 
salina) lethality test. The 50 g of eggs of A. salina 
were incubated in sea water (pH 8 ± 0,5 and 28 ºC) at 
artificial light during 24 - 36 hours for cysts 
occlusion and larvae obtaining. After hatching, they 
were collected and put into tubes containing different 
EtOH extract concentrations (2000, 1500, 1000, 500, 
and 250 μg/mL), and the blank control was always 
conduced. The set was incubated at artificial light for 
24 h, and then the survivor larvae were counted to 
determine the LC50 using the Probit method. The 
bioassay was repeated three times. As the measure of 
extract toxicity, the LC50 value lower than 1000 
μg/mL is considered bioactive (Meyer et al., 1982). 
These authors described a lethal concentration (LC50) 
based on the toxicity of substances to the larvae of A. 
salina. According to the scale, LC50 values < 500 
μg.mL−1 indicate toxicity, LC50 between 500 and 
1000 μg.mL−1 denote moderate toxicity, while LC50 
> 1000 μg.mL−1 suggest lack of toxicity. 
 
RESULTS 
Tables 1 and 2 show that with the exception of strain 
ATCC, erythromycin was effective against all other 
strains at high concentrations, ranging from 3.90 to 
83.33 mg.mL
-1
. The X. americana and S. brasiliensis, 
except for strain 02 and ATCC, showed antimicrobial 
potential against all tested strains with MIC values 
lower than that of erythromycin, being thus more 
effective. 
Table 1  
MIC of erythromycin and extracts Ximenia americana against the strains of Staphylococcus aureus 
 
Staphylococcus aureus 
MIC (mg.mL
-1
) 
 
ERI 
Bark Leaves 
MIC MICc FIC E MIC MICC FIC E 
ATCC 25923 0.01 2.08   0.02 2.29 I 1.04     0.02 2.29 I 
SA 01 83.33 4.16 21.16 0.25 S 2.08 125.00 1.50 I 
SA 02 0.60 2.08   1.73 2.89 I 2.08     1.60 2.67 I 
SA 03 42.32 4.16 15.38 0.36 S 4.16 125.00 2.95 I 
SA 04 26.04 4.16 10.42 0.40 S 2.08   31.24 1.20 I 
SA 05 20.83 2.08 20.83 1.00 I 2.08   31.24 1.50 I 
SA 06   3.90 1.04   2.30 0.59 I 1.04     3.90 1.00 I 
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ERI, Erythromycin estolate; MIC, Minimal Inhibitory Concentration; MICC, MIC combined; FIC, 
Fractional Inhibitory Concentration; E, Effect; S, Synergic; I, Indifferent 
Table 2 
MIC of erythromycin and extracts Schinopsis brasiliensis against the strains of Staphylococcus aureus 
 
ERI, Erythromycin estolate; MIC, Minimal Inhibitory Concentration; MICC, MIC combined; FIC, 
Fractional Inhibitory Concentration; E, Effect; S, Synergic; I, Indifferent 
 
 
 The combination of ethanol extracts (EtOH) 
from the bark of X. americana with erythromycin, 
decreased the MIC of the antibiotic against nearly all 
resistant strains and showing synergistic effect 
against SA01, SA03 and SA04 with FIC's ranging 
between 0.40 and 0.25. However, this effect was not 
observed in the drug combination with EtOH from 
leaf, which showed FIC values considered 
indifferent, despite the extract showing a good 
antibacterial potential when alone. 
The extracts of S. brasiliensis showed a 
promising antimicrobial activity when tested alone, 
and when combined with the drug, this reduced the 
MIC against most strains tested. However, a 
synergistic effect was observed only on strains 01 
and 03 for the bark extract and strain 03 for leaf 
extract. 
The results showed that the extract of S. 
brasiliensis leaf present LC50 = 512  μg/mL, and X. 
americana leaf present LC50 = 2.077 μg/mL. S. 
brasiliensis and  X. americana  bark was studied by 
Silva et al. (2012) showed that the extract of S. 
brasiliensis present LC50 = 428  μg/mL and X. 
americana  present LC50 = 4.262. 
 
DISCUSSION 
With the emergence of resistance to antibiotics, 
natural plant products can be a good alternative for 
therapeutic treatments (Lu et al., 2007; Coutinho et 
al., 2009b). 
Several authors have studied the 
antimicrobial properties of X. americana and S. 
brasiliensis (Ogunleye & Ibitoye, 2003; Omer & 
Elnima, 2003; James et al., 2007; Kubmarawa et al., 
2007; Maiakai et al., 2009; Saraiva et al., 2011; Le 
et al., 2012; Silva et al., 2012) and the association of 
extracts or compounds isolated from medicinal 
plants with antibiotics from the classes of 
macrolides, -lactams, quinolones and 
aminoglycosides in resistant strains of 
Staphylococcus aureus, Escherichia coli and 
Pseudomonas aeruginosa (Coutinho et al., 2008; 
Coutinho et al., 2009a; Coutinho et al., 2009b; 
Adwan & Abu-Shanab, 2010; Zuo et al., 2011; 
Fernandes et al., 2012; Matias et al., 2013). 
The combination of two or more drugs may 
result in additive, synergistic and antagonistic 
effects, because the use of multiple drugs may target 
multiple targets, multiple subpopulations, or multiple 
diseases simultaneously. The use of multiple drugs 
with different mechanisms of action may also direct 
the effect against single target or a disease and treat 
it more effectively. And with the same mechanisms 
of action may compete for the same site of 
interaction. If drug A has an effect and drug B has no 
effect and if in combination they have an effect that 
 
Staphylococcus aureus 
MIC (mg.mL
-1
) 
 
ERI 
Bark Leaves 
MIC MICC FIC E MIC MICC FIC E 
ATCC 25923   0.01 1.04   0.01 0.76 I 1.04   0.01 1.14 I 
SA 01 83.33 1.04   1.95 0.02 S 1.04 42.32 0.51 I 
SA 02   0.60 1.04   1.40 2.33 I 1.04   0.61 1.01 I 
SA 03 42.32 1.04   6.18 0.15 S 1.04   0.98 0.02 S 
SA 04 26.04 1.04 31.25 1.20 I 1.04 31.25 1.20 I 
SA 05 20.83 1.04 26.04 1.25 I 1.04 31.25 1.50 I 
SA 06   3.90 1.04   2.60 0.67 I 1.04   2.28 0.58 I 
 
da Silva et al.   Modulation of the erythromycin resistance of medicinal plants 
Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas/96 
 
is greater than that of drug A, then it is enhancement 
or potentiation. We can describe the effect simply as 
percent enhancement or -fold of potentiation. If A 
and B alone each has an effect, then in combination 
they may produce a synergistic, an additive, or an 
antagonistic effect. By definition, synergism is an 
effect that is more than additive, whereas the 
definition for antagonism is an effect that is less than 
additive. And the defining of additive effect is the 
combined effect predicted by the mass-action law 
principle that occur in the absence of synergism or 
antagonism (Tallarida, 2001; Chou, 2006; Tallarida, 
2012). 
The combination of drugs may result in a 
synergistic action and The possible favorable 
outcomes for synergism include 1) increasing the 
efficacy of the therapeutic effect, 2) decreasing the 
dosage but increasing or maintaining the same 
efficacy to avoid toxicity, 3) minimizing or slowing 
down the development of drug resistance, and 4) 
providing selective synergism against target (or 
efficacy synergism) versus host (or toxicity 
antagonism). For these therapeutic benefits, drug 
combinations have been widely used and became the 
leading choice for treating the most dreadful 
diseases, such as cancer and infectious diseases, 
including AIDS (Tallarida, 2006; Chou, 2006).   
The antimicrobial activity and synergism 
observed between extracts of these plants and the 
antibiotic may possibly be related to the presence of 
phenolic compounds that when interacting with 
Erythromycin favored its mechanisms of action. Sato 
et al. (2004) and Cushnie & Lamb, (2005) 
corroborate this idea by reporting that these 
phytochemicals exhibit antimicrobial activity and, 
combined with certain antibiotics, promote 
modulation by changing the profile of bacterial 
resistance. 
The synergistic effect observed between 
plant extracts and antibiotics indicates that this 
combination was more effective than the activity 
displayed by the agents tested alone. It may be 
related to differences in the mechanisms of actions 
(Pei et al., 2009). This effect may be result from the 
action of the active agents in different targets alone 
or combined to overcome the microbial resistance 
mechanism. The flavonoids and polyphenols may 
have interacted with the antibiotic improving the 
mechanisms of action in the target sites for which it 
was intended (Olajuyigbe & Afolayan, 2012). The 
resistance acquired by S. aureus is usually related to 
the efflux pumps that effectively enhance the 
antibiotic activity of erythromycin by reducing the 
concentrations needed to inhibit the growth of drug 
resistant strains (Oliveira et al., 2011). 
The mechanisms of action that substances 
from plants may have against the microorganisms 
are varied, and they can act as regulators of 
intermediary metabolism by activating or blocking 
enzymatic reactions directly affecting the enzymatic 
synthesis whether in nuclear or ribosomal level, or 
even changing the membrane structures. These 
mechanisms may be obtained by combining 
secondary metabolites, one or more plant extracts 
with drugs or antibiotics, causing the blockage of 
one or more targets through the synergistic-agonist 
action of the different therapeutic components 
(Nicolson et al., 1999; Hemaiswarya et al., 2008; 
Coutinho et al., 2009a; Coutinho et al., 2009b; 
Wagner & Ulrich-Merzenich, 2009). 
Macrolides are bacteriostatic that prevents 
microbial proliferation by intervening in protein 
synthesis, through its reversible binding to the 50S 
ribosomal subunits of susceptible microorganisms. 
However, the resistance to these antibiotics usually 
results from one of the following four mechanisms: 
drug efflux via proteins; ribosomal protection by 
production of methylated enzymes that modify the 
ribosomal target and decrease the drug binding; drug 
hydrolysis by esterases production and mutations 
which alter the 50S ribosomal protein (Guimarães et 
al., 2010). 
 The results of the bioassay A. salina showed 
that extracts of X. americana presented absence of 
toxicity, while extracts from the leaves of S. 
brasiliensis can be considered moderately toxic. 
 
CONCLUSION 
Thus, these results indicate the antimicrobial and 
modulator potential of X. americana and S. 
brasiliensis extracts and can be an interesting 
alternative for the therapy of infectious diseases 
caused by resistant strains of S. aureus. Although, 
the extract of S. brasiliensis denote moderate toxicity 
against A. salina. Studies in vivo of toxicity are 
essential. 
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